RGLS Regulus Therapeutics Inc

USD 1.53 +0.01 ( +0.66)%
Icon

Regulus Therapeutics Inc (RGLS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.53

+0.01 (+0.66)%

USD 0.09B

0.26M

USD 8.86(+478.90%)

USD 5.00 (+226.80%)

Icon

RGLS

Regulus Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.53
+0.01 ( +0.66)%

Regulus Therapeutics Inc (RGLS) Stock Forecast

Show ratings and price targets of :
USD 8.86
(+478.90%)

Based on the Regulus Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Regulus Therapeutics Inc is USD 8.86 over the next 12 months. Regulus Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Regulus Therapeutics Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Regulus Therapeutics Inc’s stock price was USD 1.53. Regulus Therapeutics Inc’s stock price has changed by +7.75% over the past week, +6.25% over the past month and +14.18% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...